FROM PRESS
to presentations

News

October 9, 2024
REVALESIO’S INVESTIGATIONAL TREATMENT RNS60 PROTECTS MITOCHONDRIA IN PRECLINICAL MODEL OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
September 17, 2024
REVALESIO’S INVESTIGATIONAL RNS60 EXTENDED SURVIVAL IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) IN POST-HOC ANALYSIS OF PHASE 2 INVESTIGATOR-SPONSORED TRIAL
February 7, 2024
REVALESIO ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 2 RESCUE STUDY OF RNS60 IN PATIENTS WITH ACUTE ISCHEMIC STROKE IN LATE-BREAKING ORAL PRESENTATION AT ISC 2024
All news

Publications

January 2024
RNS60 shows neuroprotective effect in a mouse model of transient focal cerebral ischemia
March 2023
RNS60 induces expression of DJ-1, an important protein in Parkinson's disease, in neuronal cells
October 2022
RNS60 Shows Protective Effects in Cardiac Ischemic Injury
All Publications